Wuhan Institute of Biological Products Co., Ltd.
Establishment time : 1967
website : http://www.wibp.com.cn/
Main Product : Vaccines, biological products
Company Profile
Wuhan Institute of Biological Products Co., Ltd. is a well-established company founded in 1967. Specializing in the production of vaccines and biological products, the company has a strong presence in China and international markets, particularly in Southeast Asia and Africa. With a medium-sized company size, Wuhan Institute of Biological Products Co., Ltd. is known for its high-quality products and competitive pricing, making it a leading player in the industry. Visit their website for more information on their products and services.
Chengdu Institute of Biological Products Co., Ltd.
Establishment time : 1967
website : www.cdibp.com.cn
Main Product : Vaccines, biological products
Company Profile
Chengdu Institute of Biological Products Co., Ltd. is a leading biopharmaceutical company in China, specializing in the research, development, and production of vaccines and biological products. Established in 1967, the company has grown to become a key player in the healthcare industry, serving both domestic and international markets with a wide range of high-quality products. With a large company size and a strong competitive position, Chengdu Institute of Biological Products Co., Ltd. continues to innovate and expand its presence in the global market.
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd.
Establishment time : 1994
website : http://www.tianyuanbio-pharm.com/
Main Product : Recombinant human insulin, insulin analogs, and other biopharmaceutical products
Company Profile
Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. is a biopharmaceutical company specializing in the production of insulin and other biopharmaceutical products. Founded in 1994, the company has grown to become a key player in the global market, with a strong presence in China, Asia, Europe, and North America. With a focus on innovation and quality, Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. continues to expand its product portfolio and reach new markets.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Changchun BCHT Biotechnology Co., Ltd.
Establishment time : Changchun BCHT Biotechnology Co., Ltd. was founded in 2002.
website :
Main Product : Their main markets are global, serving customers worldwide.
Company Profile
They have established a solid reputation in the biotechnology industry for their reliable and effective peptide solutions.
Shenzhen Kangtai Biological Products Co., Ltd.
Establishment time : Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992.
website :
Main Product : With over 10,000 employees, Kangtai is one of the largest biopharmaceutical companies in China.
Company Profile
Kangtai's mission is to improve public health through the development of innovative vaccines and biopharmaceutical products.
